Eton Pharmaceutcials Inc (ETON) Stock Price, Quote & News

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 847 787 7361

Website: www.etonpharma.com

Address:

21925 W. Field Parkway, Suite 235, Deer Park, United States

Tennis_4567 Jun. 16 at 11:19 PM

$ETON David krempa sold some shares as well.

0 · Reply

Bornjever Jun. 16 at 3:38 PM

$ETON a positive number on earnings last two times with new drug approval recently Zacks has moved this to a number 2 group in their best companies list so August 7 is going to be a happy day for all of us shareholders that refuse to sell at stupid cheap prices.

0 · Reply

RunsWithDogs Jun. 13 at 4:32 PM

$ETON I'm pretty impressed with the volume and strength here today. Already over ave daily volume not even half way through the trading session. Maybe some tutes and whales thinking this is the bottom even on a down market day! We will see.

2 · Reply

oaksapollo Jun. 13 at 12:50 PM

$ETON Opaleye bought the dip https://www.sec.gov/Archives/edgar/data/1710340/000164117225014868/xslF345X05/ownership.xml

2 · Reply

badgermobile Jun. 13 at 12:46 PM

$ETON if it goes below $14 time to load up, this one is golden in 6 months probably 20 at minimum maybe 25 if market is still in this range

0 · Reply

OracleofOntario Jun. 12 at 8:05 PM

$ETON no need to panic. Or maybe panic. I have no clue

0 · Reply

Chomo Jun. 11 at 9:51 PM

$ETON coming to 200 dma? solid green line is 200 dma, dotted green line is vwap from 252 days ago.

1 · Reply

sshd Jun. 11 at 2:42 PM

$ETON i got bored of waiting for this to go up for 4 years and sold at a loss in 2023. Now look at it. 😢

0 · Reply

Dbarnyard Jun. 10 at 6:54 PM

$ETON stock is looking weaker than it has in a long, long time. Still holding about 2,000 of my original 16,000 shares, but wouldn't be surprised to see it hit $10 again, which is, frankly, where it probably belongs.

3 · Reply

RunsWithDogs Jun. 10 at 5:21 PM

$ETON Oaks, Depends on what you consider near term. I've been here for more than 4 years now ($3.75 ave). Near term for me is within 3 mos. I'm guessing by 3Q earnings we will probably be around $20 again. Until then, I think it's likely to continue down to low teens and then start back up in a few more weeks. If we get news on the ET-400 launch and/or new coverage then the slide will likely end sooner. GLTA bulls!

1 · Reply

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

May 29, 2025, 12:42 PM EDT - 18 days ago

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

May 28, 2025, 5:28 PM EDT - 19 days ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 21, 2025, 2:57 AM EDT - 26 days ago

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

May 14, 2025, 4:30 PM EDT - 4 weeks ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025, 10:40 PM EDT - 4 weeks ago

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 4 weeks ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 6 weeks ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Apr 28, 2025, 6:50 AM EDT - 7 weeks ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Apr 1, 2025, 7:00 AM EDT - 2 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Mar 25, 2025, 2:30 AM EDT - 2 months ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

Mar 18, 2025, 7:42 PM EDT - 3 months ago

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:50 AM EDT - 3 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Mar 14, 2025, 6:50 AM EDT - 3 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Mar 4, 2025, 10:00 AM EST - 3 months ago

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Mar 4, 2025, 6:50 AM EST - 3 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Mar 3, 2025, 6:50 AM EST - 3 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Feb 7, 2025, 6:50 AM EST - 4 months ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Feb 6, 2025, 6:50 AM EST - 4 months ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Jan 3, 2025, 6:50 AM EST - 5 months ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Dec 20, 2024, 6:50 AM EST - 6 months ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Dec 3, 2024, 6:50 AM EST - 6 months ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 25, 2024, 6:50 AM EST - 7 months ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Nov 12, 2024, 8:01 PM EST - 7 months ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 7 months ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 7 months ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 3, 2024, 6:30 AM EDT - 9 months ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

Aug 22, 2024, 4:30 PM EDT - 10 months ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 11, 2024, 8:15 AM EDT - 11 months ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 5:30 PM EDT - 11 months ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

May 11, 2024, 9:34 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Apr 29, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 22, 2024, 2:20 AM EDT - 1 year ago

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

Mar 22, 2024, 2:00 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Mar 14, 2024, 9:38 PM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 29, 2024, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

Feb 21, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

Feb 2, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

Nov 9, 2023, 5:18 PM EST - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

Oct 30, 2023, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Oct 4, 2023, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

Sep 11, 2023, 3:29 PM EDT - 1 year ago

Eton Pharmaceuticals: Fading The Rally

Aug 23, 2023, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Tennis_4567 Jun. 16 at 11:19 PM

$ETON David krempa sold some shares as well.

0 · Reply

Bornjever Jun. 16 at 3:38 PM

0 · Reply

RunsWithDogs Jun. 13 at 4:32 PM

2 · Reply

oaksapollo Jun. 13 at 12:50 PM

$ETON Opaleye bought the dip https://www.sec.gov/Archives/edgar/data/1710340/000164117225014868/xslF345X05/ownership.xml

2 · Reply

badgermobile Jun. 13 at 12:46 PM

$ETON if it goes below $14 time to load up, this one is golden in 6 months probably 20 at minimum maybe 25 if market is still in this range

0 · Reply

OracleofOntario Jun. 12 at 8:05 PM

$ETON no need to panic. Or maybe panic. I have no clue

0 · Reply

Chomo Jun. 11 at 9:51 PM

$ETON coming to 200 dma? solid green line is 200 dma, dotted green line is vwap from 252 days ago.

1 · Reply

sshd Jun. 11 at 2:42 PM

$ETON i got bored of waiting for this to go up for 4 years and sold at a loss in 2023. Now look at it. 😢

0 · Reply

Dbarnyard Jun. 10 at 6:54 PM

3 · Reply

RunsWithDogs Jun. 10 at 5:21 PM

1 · Reply

Chomo Jun. 10 at 12:15 AM

$ETON this is pupu now...-26% from that high in no time.

0 · Reply

oaksapollo Jun. 9 at 2:12 PM

$ETON I can't decide if this is going to $12 or $20 in the near term. Neither would surprise me. Any thoughts?

2 · Reply

momoinvestor Jun. 6 at 8:52 PM

$ETON Sean has delivered big time... if he wants to diversify his wealth a bit, I'm sure not complaining. Guy still has huge skin in the game. Now if he wasn't executing and he was selling, well, then I'm upset.

1 · Reply

oaksapollo Jun. 5 at 9:23 PM

$ETON Sean selling and not to pay taxes, just plain selling. Not a great sign, but then the stock is up like 400% in the last year so maybe he's just buying a lambo or something https://ir.etonpharma.com/node/8806/html

1 · Reply

badgermobile Jun. 5 at 12:09 PM

$ETON The big sale that everyone is talking about was CEO Sean sold 210,000 shares the other day, founders shares from 2017. This was just his first sale and things will probably settle down for awhile now and begin the move higher

1 · Reply

Chomo Jun. 3 at 9:39 PM

$ETON another liquidation day...high volume

0 · Reply

BradBreath Jun. 3 at 7:15 PM

$ETON profit taking i suppose ? Or a offering perhaps ?who knows , always something ya know i am hanging in a little bit may add gets to 16.50

0 · Reply

BixbyKnolls Jun. 3 at 3:43 PM

$ETON ouch? Why the drop?

0 · Reply

RunsWithDogs Jun. 2 at 8:05 PM

$ETON It may not be managements style, but it would be nice to see a press release on the day of ET-400 launch! It would really help shareholders out by ETON patting themselves on the back once in a while... Maybe another analyst might take an interest, or potential retail buyers, etc. Maybe I'm asking too much?

0 · Reply

Jfoo May. 30 at 6:40 PM

$ETON Looks like the stock is absorbing all the fda flippers nicely

0 · Reply

Bornjever May. 30 at 1:17 PM

$ETON HC Wainwright raised target to 36.00 so I would be happy with 26- but the 19.00 is way too low. Just look at ARQT is shorted to death and minimum target is 16.00 to 18.00 and ARQT to head up Goldman Sachs’s Conference June 9-11 and patience will pay as the wealthy do not need the cash. Worst case 17-18 per share as we hit 17.75 in March before this latest approval and at least 325 million revenue for this year. V

0 · Reply

Chomo May. 29 at 10:08 PM

$ETON engulfing day on highest volume in a year, someone got out on that news..

1 · Reply

Market Cap	383.50M
Revenue (ttm)	39.01M
Net Income (ttm)	-3.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	32.98
Profit Margin	-9.79%
Debt to Equity Ratio	1.23

Volume	324,000
Avg Vol	351,312
Day's Range	N/A - N/A
Shares Out	26.82M
Stochastic %K	1%
Beta	1.28
Analysts	Strong Sell
Price Target	$29.67